BD
Congress trade
Rep. Byron Donalds (R-FL) sold $1K-$15K of Regeneron Pharmaceuticals, Inc. (REGN) stock
Byron Donalds, U.S. Representative (R-FL), disclosed a sale of Regeneron Pharmaceuticals, Inc. (REGN) stock worth $1K-$15K in a STOCK Act filing on May 24, 2025.
The trade happened on Apr 10, 2025, 44 days before it was made public.
REGN has moved +34.6% since the trade date, from $546.39 to $735.20 (Oct 2, 2026 close).
- Traded
- Apr 10, 2025
- Disclosed
- May 24, 2025
- Filing delay
- 44 days
- Price since
- +34.6%
- Source
- STOCK Act disclosure
Other trades in this disclosure (7)
More REGN insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.